Literature DB >> 28844678

Antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities of the essential oil of Psidium guineense Sw. and spathulenol.

Kamilla Felipe do Nascimento1, Flora Martinez Figueira Moreira2, Joyce Alencar Santos3, Candida Aparecida Leite Kassuya4, Julio Henrique Rosa Croda5, Claudia Andrea Lima Cardoso6, Maria do Carmo Vieira7, Ana Lúcia Tasca Góis Ruiz8, Mary Ann Foglio9, João Ernesto de Carvalho10, Anelise Samara Nazari Formagio11.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Leaves from Psidium guineense Sw. are used in popular medicine for the treatment of inflammatory disease. However, there is no scientific evidence demonstrating this activity. AIM OF THE STUDY: To evaluate the antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities of the essential oil of P. guineense and spathulenol (a major constituent). The study was conducted in part to provide evidence supporting the ethnobotanical use of the leaves of this species.
MATERIAL AND METHODS: The essential oil (EOPG) was extracted from the leaves of P. guineense by hydrodistillation and analysed by gas chromatography-mass spectrometry (GC-MS). The major compound, spathulenol (PG-1), was isolated in a chromatographic column and characterized by nuclear magnetic resonance (NMR). EOPG and PG-1 were evaluated in vitro for antioxidant activity by DPPH, ABTS and MDA methods; anti-inflammatory potential was assessed using two models, including pleurisy and oedema, in mice. The impact of EOPG and PG-1 on cell proliferation was determined via spectrophotometric quantification of the cellular protein content using a sulforhodamine B assay, and anti-Mycobacterium tuberculosis activity was determined using the REMA method.
RESULTS: A total of 38 components were identified from the EOPG, with the sesquiterpenic alcohol spathulenol (PG-1) (80.7%) being the major constituent. EOPG and PG-1 exhibited the highest antioxidant activities in the DPPH and MDA system compared with reference standard, with IC50 values ranging from 26.13 to 85.60μg/mL. Oral administration of EOPG and PG-1 showed significant inhibition in the Cg-induced mice paw oedema and pleurisy model. The EOPG (GI50 = 0.89μg/mL) and PG-1 (GI50 = 49.30μg/mL) were particularly effective against the ovarian cancer cell line. Both showed moderate antimycobacterial activity.
CONCLUSION: For the first time, this study demonstrated the antioxidant, anti-inflammatory, antiproliferative and antimycobacterial properties of the essential oil of P. guineense (leaves were collected in Dourados-MS) and spathulenol, collaborating the etnhopharmacologycal use of this plant due to its an anti-inflammatory effect.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  (1)H NMRProton nuclear magnetic resonance of hydrogen; (13)C NMRCarbon-13 nuclear magnetic resonance; 786-0Renal; AA%Antioxidant activity; ABTS2,2′-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid); Anti-Mycobacterium tuberculosis; Antioxidant; Antiproliferative; Araçá; BHTButylated hydroxytoluene; CCColumn chromatography; CDCl(3)Deuterated chloroform; CO(2)Carbon dioxide; Cgλ–carrageenan; DEXADexamethasone; DMSODimethylsulfoxide; DOXDoxorubicin; DPPH2,2-Diphenyl-1-picrylhydrazyl; EOPG-1Essential oil of P. guineense-sub-fraction 1; EOPG-4Essential oil of P. guineense-sub-fraction 4; EOPG-7Essential oil of P. guineense-sub-fraction 7; EOPGEssential oil of Psidium guineense; GC-MSGas chromatograph - mass spectrometry; GI(50)Growth inhibitory for 50% of cell; HT-29Colon cell line; HaCaTKeratinocytes; I%Inhibition percentage; IC(50)Concentration resulting in 50% inhibition; IL-1βInterleukin-1 beta; IL-6Interleukin-6; IL-8Interleukin-8; IPPIsopentenyl pyrophosphate; K-562Leukaemia; LC(50)Concentration killing 50% of cells; MCF-7Breast; MDAMalondialdehyde; MHzMegahertz; MICConcentration inhibition minimum; MM-1Matriz metalloproteinase-1; MTBMycobacterium tuberculosis; NCI-ADR/RESOvarian expressing the phenotype of multiple drug resistance; NCI-H460Lung; NCINational câncer institute; NONitric oxide; OVCAR-3Ovarian; Oedema; PBSPhosphate buffered saline; PCO-3Prostate; PG-1Compound spathulenol; Pleurisy; REMAResazurin microtiter assay; RPMI-1640Roswell park memorial institute 1640 medium; TGIGrowth inhibitory for 50% of cell; TLCThin-layer chromatography; TMSTetramethylsilane; TNF-αTumour necrosis factors-alpha; U251Glioma

Mesh:

Substances:

Year:  2017        PMID: 28844678     DOI: 10.1016/j.jep.2017.08.030

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  23 in total

1.  Oral administration of essential oil from Psidium glaziovianum Kiaersk leaves alleviates pain and inflammation in mice.

Authors:  Wêndeo Kennedy Costa; Matheus Ferreira do Nascimento; Cícero Ramon Bezerra Dos Santos; Júlio César Ribeiro Dede Oliveira FariasAguiar; Daniela Maria do Amaral Ferraz Navarro; Thiago Henrique Napoleão; Maria Tereza Dos Santos Correia; Fábio André Brayner; Alisson Macário de Oliveira; Márcia Vanusa da Silva
Journal:  Inflammopharmacology       Date:  2022-03-08       Impact factor: 4.473

Review 2.  Chemical Constituents of Essential Oils Used in Olfactory Training: Focus on COVID-19 Induced Olfactory Dysfunction.

Authors:  Sachiko Koyama; Thomas Heinbockel
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

3.  Induction of mitochondrial-dependent apoptosis by essential oil of Toona sinensis root through Akt, mTOR and NF-κB signalling pathways in human renal cell carcinoma cells.

Authors:  Yu-Chi Chen; Chiao-Ling Hsieh; Bu-Miin Huang; Yung-Chia Chen
Journal:  J Food Drug Anal       Date:  2021-09-15       Impact factor: 6.157

4.  Antihypertensive activity and vascular reactivity mechanisms of Vitex pubescens leaf extracts in spontaneously hypertensive rats.

Authors:  Ahmed Ahmed Al-Akwaa; Mohd Zaini Asmawi; Aidiahmad Dewa; Roziahanim Mahmud
Journal:  Heliyon       Date:  2020-07-31

5.  Ferulago nodosa Subsp. geniculata (Guss.) Troia & Raimondo from Sicily (Italy): Isolation of Essential Oil and Evaluation of Its Bioactivity.

Authors:  Natale Badalamenti; Vincenzo Ilardi; Sergio Rosselli; Maurizio Bruno; Filippo Maggi; Mariarosaria Leporini; Tiziana Falco; Monica R Loizzo; Rosa Tundis
Journal:  Molecules       Date:  2020-07-16       Impact factor: 4.411

6.  Chemical Composition and Antioxidant Activity of Essential Oils from Eugenia patrisii Vahl, E. punicifolia (Kunth) DC., and Myrcia tomentosa (Aubl.) DC., Leaf of Family Myrtaceae.

Authors:  Celeste de Jesus Pereira Franco; Oberdan Oliveira Ferreira; Ângelo Antônio Barbosa de Moraes; Everton Luiz Pompeu Varela; Lidiane Diniz do Nascimento; Sandro Percário; Mozaniel Santana de Oliveira; Eloisa Helena de Aguiar Andrade
Journal:  Molecules       Date:  2021-05-29       Impact factor: 4.411

7.  Chemical Composition and Immunomodulatory Activity of Essential Oils from Rhododendron albiflorum.

Authors:  Igor A Schepetkin; Gulmira Özek; Temel Özek; Liliya N Kirpotina; Andrei I Khlebnikov; Mark T Quinn
Journal:  Molecules       Date:  2021-06-15       Impact factor: 4.411

8.  Determination of the Chemical Composition and Antimicrobial Activity of Lavatera thuringiaca L. Medicinal Herb Material Extracted under Subcritical Conditions by the Liquid Carbon Dioxide Method.

Authors:  Moldir A Zhandabayeva; Kaldanay K Kozhanova; Assyl K Boshkayeva; Valeriy A Kataev; Gulbaram O Ustenova; Nadezhda G Gemejiyeva; Zhanar A Iskakbayeva
Journal:  Int J Biomater       Date:  2021-07-21

9.  Chemical variability in the essential oil of leaves of Araçá (Psidium guineense Sw.), with occurrence in the Amazon.

Authors:  Pablo Luis B Figueiredo; Renan C Silva; Joyce Kelly R da Silva; Chieno Suemitsu; Rosa Helena V Mourão; José Guilherme S Maia
Journal:  Chem Cent J       Date:  2018-05-10       Impact factor: 4.215

Review 10.  Brazilian medicinal plants with corroborated anti-inflammatory activities: a review.

Authors:  Victor Pena Ribeiro; Caroline Arruda; Mohamed Abd El-Salam; Jairo Kenupp Bastos
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.